Trials / Withdrawn
WithdrawnNCT04535895
Simultaneous Integrated Boost Technique in Breast Cancer Radiotherapy
Simultaneous Integrated Boost (SIB) Technique in the Adjuvant Radiotherapy of Breast Cancer Patients.
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Medical University of Graz · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Adjuvant radiotherapy after breast conserving surgery has been shown to improve both local control and overall survival. Dose escalation of the tumor bed by addition of a boost after whole breast radiotherapy reduces the risk of local recurrence in invasive breast cancer. Simultaneous integrated boost (SIB) techniques have been shown to provide more conformal treatment plans than conventional sequential boost, in addition, SIB enables a reduction in the overall treatment time by 1 week compared to conventional boost techniques. The proposed study is aimed at evaluating radiation-induced toxicity in patients treated with breast-conserving surgery in combination with radiotherapy using SIB technique.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Simultaneous integrated boost | Adjuvant breast cancer irradiation including simultaneous integrated boost |
Timeline
- Start date
- 2020-04-16
- Primary completion
- 2022-08-31
- Completion
- 2025-08-31
- First posted
- 2020-09-02
- Last updated
- 2022-10-12
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT04535895. Inclusion in this directory is not an endorsement.